- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 00:29 | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 00:24 | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | 1 | ASX | ||
| Mi | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | 1 | ASX | ||
| 05.09. | VITA LIFE SCIENCES LIMITED: Notification of cessation of securities - VLS | - | ASX | ||
| 02.09. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | 2 | ASX | ||
| VITA LIFE SCIENCES Aktie jetzt für 0€ handeln | |||||
| 01.09. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | 1 | ASX | ||
| 25.08. | VITA LIFE SCIENCES LIMITED: Half Year Presentation | - | ASX | ||
| 25.08. | VITA LIFE SCIENCES LIMITED: Dividend/Distribution - VLS | - | ASX | ||
| 25.08. | VITA LIFE SCIENCES LIMITED: Half Year Accounts | - | ASX | ||
| 26.06. | VITA LIFE SCIENCES LIMITED: Notification of cessation of securities - VLS | - | ASX | ||
| 24.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 23.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 22.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 18.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX | ||
| 17.06. | VITA LIFE SCIENCES LIMITED: Update - Notification of buy-back - VLS | - | ASX |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 6,425 | -1,46 % | Green Thumb Launches $50M Buyback: Time to Get Bullish on the Stock? | ||
| INDIVA | 0,016 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.06.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 20.06.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.06.2025.ISIN NameCA45580J1012 INDIVA... ► Artikel lesen | |
| ALNYLAM PHARMACEUTICALS | 386,50 | +1,23 % | Alnylam tritt Genomik-Allianz bei und treibt Entwicklung von RNA-Interferenz-Therapien voran | ||
| NEKTAR THERAPEUTICS | 46,200 | +6,45 % | Nektar announces positive phase 2b results for atopic dermatitis drug | ||
| CASSAVA SCIENCES | 1,900 | +7,77 % | Cassava Sciences, Inc.: Cassava Reports Q2 2025 Financials Results and Provides Business Update | Following positive preclinical data, simufilam development to advance with a clinical study expected to begin in H1 2026 for the potential treatment of TSC-related epilepsyRecent appointment of experienced... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 1,430 | -0,28 % | SELLAS Life Sciences Group, Inc. - 8-K, Current Report | ||
| ACADIA PHARMACEUTICALS | 20,710 | +1,22 % | TD Cowen hebt Kursziel für Acadia Pharmaceuticals auf 39 US-Dollar an | ||
| CATALYST PHARMACEUTICALS | 16,805 | -0,77 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE (amifampridine) Patent Litigation with Lupin Pharmaceuticals | CORAL GABLES, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing... ► Artikel lesen | |
| MOLECULE HOLDINGS | 0,001 | 0,00 % | Molecule Holdings Inc: Molecule Holdings amends, converts 8% debentures | ||
| NUMINUS WELLNESS | 0,027 | -100,00 % | Numinus Wellness Inc. Announces Third Quarter Fiscal 2025 Results | Vancouver, British Columbia--(Newsfile Corp. - September 3, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23) ("Numinus" or the "Company") a mental health care company focused on... ► Artikel lesen | |
| ZELIRA THERAPEUTICS | 0,230 | +16,16 % | ZELIRA THERAPEUTICS LIMITED: Director Loans | ||
| OPUS GENETICS | 1,190 | -0,67 % | Opus Genetics, Inc.: Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited... ► Artikel lesen | |
| SOLIGENIX | 2,830 | 0,00 % | Stocks Moving Premarket: Viking Therapeutics, Flexsteel Industries, Propanc Biopharma, Soligenix And Other Gainers & Losers | CANBERA (dpa-AFX) - At 8.20 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| ANI PHARMACEUTICALS | 83,50 | +3,09 % | ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Reports Record Second Quarter 2025 Financial Results and Raises 2025 Guidance | Generated record quarterly net revenues of $211.4 million, representing year-over-year growth of 53.1% on a reported basis and 37.0% on an organic basisTotal Rare Disease quarterly net revenues of... ► Artikel lesen |
VITA LIFE SCIENCES LIMITED gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VITA LIFE SCIENCES LIMITED finden Sie auf Wallstreet Online.